U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
138271138271Uremic Toxins in the ICU: Patients After Cardiac SurgeryRecruitingNo Results AvailableRenal FailureProcedure: Dialysis during 4 hours|Procedure: Dialysis during 6 hours|Procedure: Dialysis during 8 hourshttps://ClinicalTrials.gov/show/NCT00752804
138272138272Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.CompletedHas ResultsAnemiaDrug: Peginesatidehttps://ClinicalTrials.gov/show/NCT00752791
138273138273Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With TysabriTerminatedNo Results AvailableMultiple SclerosisOther: pet-scan FDG-F18https://ClinicalTrials.gov/show/NCT00752778
138274138274The Effects of Bariatric Surgery Weight Loss on Knee Pain in Patients With Osteoarthritis of the KneeCompletedNo Results AvailableKnee Pain|Knee Osteoarthritishttps://ClinicalTrials.gov/show/NCT00752765
138275138275The Acute Cardiovascular Effects of Marathon Running Using Magnetic Resonance ImagingCompletedNo Results AvailableMyocardial Ischemia|Left Ventricular Systolic Dysfunction|Elevated Cardiac Enzymeshttps://ClinicalTrials.gov/show/NCT00752752
138276138276Selenium in Treating Patients With Prostate CancerCompletedNo Results AvailableProstate CancerDietary Supplement: selenium|Other: placebohttps://ClinicalTrials.gov/show/NCT00752739
138277138277Effect of Orlistat in Body CompositionCompletedHas ResultsObesity|OverweightDrug: Orlistat|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00752726
138278138278Strain-Encoded Magnetic Resonance Imaging in Acute Myocardial InfarctionCompletedNo Results AvailableAcute Myocardial InfarctionProcedure: cardiac MRIhttps://ClinicalTrials.gov/show/NCT00752713
138279138279Resistance Exercise Training For Radically Treated Respiratory CancerCompletedNo Results AvailableRespiratory CancerOther: Conventional resistance training|Other: Whole body vibration resistance traininghttps://ClinicalTrials.gov/show/NCT00752700
138280138280A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected AdultsCompletedNo Results AvailableHepatitis CDrug: ABT-072|Drug: placebohttps://ClinicalTrials.gov/show/NCT00752687
138281138281Neuromuscular Balance in Low Back PainCompletedNo Results AvailableLow Back PainOther: Neuromuscular balancehttps://ClinicalTrials.gov/show/NCT00752674
138282138282An Exploratory Study of Tramadol Hydrochloride in Patients With Osteoarthritis of the Knee or Low Back PainCompletedNo Results AvailableOsteoarthritis|Low Back PainDrug: Tramadol Hydrochloride; JNS013https://ClinicalTrials.gov/show/NCT00752661
138283138283TMC435350-TiDP16-C106: A Phase I Trial to Compare the Bioavailability and Plasma Pharmacokinetics After a Single Oral Dose of TMC435350 of 2 Different Solid Formulations Relative to a Powder Blend CapsuleCompletedNo Results AvailableHepatitis C|HCVDrug: TMC435350https://ClinicalTrials.gov/show/NCT00752648
138284138284Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne VulgarisCompletedNo Results AvailableAcne VulgarisDrug: Norgestimate-ethinyl estradiol; Cyproterone acetate-ethinyl estradiolhttps://ClinicalTrials.gov/show/NCT00752635
138285138285Treatment With Infliximab in a Medical Setting (Study P05587)TerminatedHas ResultsCrohn's DiseaseBiological: Infliximab 5 mg/kg|Biological: Infliximab 5 mg/kg every 6 weeks|Biological: Infliximab 7 mg/kg every 8 weekshttps://ClinicalTrials.gov/show/NCT00752622
138286138286Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.CompletedHas ResultsAnemiaDrug: Peginesatidehttps://ClinicalTrials.gov/show/NCT00752609
138287138287Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One PatientCompletedNo Results AvailableCongestive Heart FailureDrug: Azimilide 2HClhttps://ClinicalTrials.gov/show/NCT00752596
138288138288Peritoneal Dialysis Versus HaemodialysisRecruitingNo Results AvailableHemodialysisProcedure: Peritoneal dialysis|Procedure: Haemodialysishttps://ClinicalTrials.gov/show/NCT00752583
138289138289A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal CarcinomaCompletedNo Results AvailableCancer|Carcinoma|Colon Cancer|Colorectal Cancer|Gastrointestinal Cancer|Metastases|Metastatic Cancer|Metastatic Colorectal Cancer|Oncology|Rectal CancerDrug: AMG 386|Drug: AMG 386 Placebo|Drug: FOLFIRIhttps://ClinicalTrials.gov/show/NCT00752570
138290138290Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMDCompletedNo Results AvailableOsteoporosisDrug: rhBMP-2/CPM injection and bisphosphonates, calcium, and vitamin D (oral bisphosphonate therapy)|Drug: rhBMP-2/CPM injection and bisphosphonates, calcium, and vitamin D (oral bisphosphonate therapy)|Drug: bisphosphonates, calcium, and vitamin Dhttps://ClinicalTrials.gov/show/NCT00752557
138291138291TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male VolunteersCompletedNo Results AvailableHCVDrug: TMC435350https://ClinicalTrials.gov/show/NCT00752544
138292138292Effectiveness of Home Automated Telemanagement in Chronic Obstructive Pulmonary DisorderCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveBehavioral: Home Automated Telemanagement (HAT)https://ClinicalTrials.gov/show/NCT00752531
138293138293A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma PatientsCompletedNo Results AvailableRefractory|Multiple Myeloma|RelapseDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00752518
138294138294A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.CompletedNo Results AvailableFibromyalgiaDrug: Esreboxetine|Drug: Esreboxetinehttps://ClinicalTrials.gov/show/NCT00752505
138295138295Acceleration of Recovery From General Anesthesia - Efficacy of Isocapnic Hyperpnoea in Obese Patients Undergoing Isoflurane AnesthesiaCompletedNo Results AvailableRecovery Time From Isoflurane Anesthesia in Obese PatientsOther: Isocapnic Hyperpnoeahttps://ClinicalTrials.gov/show/NCT00752492
138296138296Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant ToleranceTerminatedNo Results AvailableKidney TransplantBiological: Mesenchymal stem cells infusion, Basiliximab,Methylprednisolone,RATG ,Cyclosporine ,Mycophenolate mofetil|Drug: Basiliximab, Methylprednisolone,RATG,Cyclosporine,Mycophenolate mofetilhttps://ClinicalTrials.gov/show/NCT00752479
138297138297A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or SeparatelyCompletedNo Results AvailableHuman Volunteers|MigraineDrug: Topiramate; flunarizinehttps://ClinicalTrials.gov/show/NCT00752466
138298138298Uremic Toxins in the Intensive Care Units (ICU): Patients With Lactate AcidosisRecruitingNo Results AvailableAcute Renal FailureProcedure: Dialysis during 4 hours|Procedure: Dialysis during 6 hours|Procedure: Dialysis during 8 hourshttps://ClinicalTrials.gov/show/NCT00752453
138299138299Inspiratory Muscle Training in Patients With Autonomic NeuropathicRecruitingNo Results AvailableDiabetes Mellitus|Diabetic Autonomic NeuropathyOther: Inspiratory muscle training (IMT)https://ClinicalTrials.gov/show/NCT00752440
13830013830024-Week Open Label Extension to a Randomized, 6-Week Double Blind, Placebo Controlled Study, to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Paliperidone ER OROS®https://ClinicalTrials.gov/show/NCT00752427

* Görseller ve İçerik tekif hakkına sahip olabilir